Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Precigen Inc (NASDAQ: PGEN) closed at $1.53 in the last session, up 11.68% from day before closing price of $1.37. In other words, the price has increased by $11.68 from its previous closing price. On the day, 1.97 million shares were traded. PGEN stock price reached its highest trading level at $1.55 during the session, while it also had its lowest trading level at $1.39.
Ratios:
We take a closer look at PGEN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.76 and its Current Ratio is at 4.76. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 09 ’24 when Perez Jeffrey Thomas bought 58,823 shares for $0.85 per share. The transaction valued at 50,000 led to the insider holds 743,097 shares of the business.
KIRK RANDAL J bought 23,529,411 shares of PGEN for $19,999,999 on Aug 09 ’24. The Director now owns 64,547,214 shares after completing the transaction at $0.85 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 449885792 and an Enterprise Value of 385695744. For the stock, the TTM Price-to-Sale (P/S) ratio is 114.77 while its Price-to-Book (P/B) ratio in mrq is 11.63. Its current Enterprise Value per Revenue stands at 98.266 whereas that against EBITDA is -4.277.
Stock Price History:
The Beta on a monthly basis for PGEN is 1.78, which has changed by 0.07746482 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $2.17, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is -8.10%, while the 200-Day Moving Average is calculated to be 24.49%.
Shares Statistics:
According to the various share statistics, PGEN traded on average about 1.76M shares per day over the past 3-months and 1404820 shares per day over the past 10 days. A total of 292.87M shares are outstanding, with a floating share count of 162.39M. Insiders hold about 44.77% of the company’s shares, while institutions hold 25.71% stake in the company. Shares short for PGEN as of 1743379200 were 23904722 with a Short Ratio of 13.59, compared to 1740700800 on 21571396. Therefore, it implies a Short% of Shares Outstanding of 23904722 and a Short% of Float of 12.379999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
